Clinical Trial Detail

NCT ID NCT04029922
Title Study of MT-5111 in HER2-positive Solid Tumors (MT-5111)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Molecular Templates, Inc.
Indications

gastroesophageal adenocarcinoma

breast cancer

Advanced Solid Tumor

gastric adenocarcinoma

Therapies

MT-5111

Age Groups: adult senior

Additional content available in CKB BOOST